Pasar al contenido principal

MECANISMOS MOLECULARES DE REGULACION DEL PROCESAMIENTO ALTERNATIVO DE PRECURSORES DE ARN MENSAJERO Y SU RELEVANCIA EN CANCER

PID2020-114630GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Intron detention tightly regulates the stemness/differentiation switch in the adult neurogenic niche

  • González Iglesias, Ainara
  • Arcas Mantas, Aida
  • Domingo Muelas, Ana
  • Mancini, Estefanía
  • Galcerán, Joan
  • Valcárcel, J. (Juan)
  • Fariñas, Isabel
  • Nieto, M. Ángela
The adult mammalian brain retains some capacity to replenish neurons and glia, holding promise for brain regeneration. Thus, understanding the mechanisms controlling adult neural stem cell (NSC) differentiation is crucial. Paradoxically, adult NSCs in the subependymal zone transcribe genes associated with both multipotency maintenance and neural differentiation, but the mechanism that prevents conflicts in fate decisions due to these opposing transcriptional programmes is unknown. Here we describe intron detention as such control mechanism. In NSCs, while multiple mRNAs from stemness genes are spliced and exported to the cytoplasm, transcripts from differentiation genes remain unspliced and detained in the nucleus, and the opposite is true under neural differentiation conditions. We also show that m6A methylation is the mechanism that releases intron detention and triggers nuclear export, enabling rapid and synchronized responses. m6A RNA methylation operates as an on/off switch for transcripts with antagonistic functions, tightly controlling the timing of NSCs commitment to differentiation., This work was supported by grants to M.A.N. from the Spanish Ministry of Science and Innovation (MCI PID2021-125682NB-I00), Instituto de Salud Carlos III (CIBERER/19/3.1), and Generalitat Valenciana (GVA) (ISIC 2012/010 plus Prometeo Programme 2017/150 and 2021/045). Work in I.F.’s lab was supported by MICIU grants PID2020-117937GB-I00, RED2018- 102723-T, CB06/05/0086 (CIBERNED), and RD16/0011/0017 (RETIC Tercel) plus Prometeo 2017/030. Work in J.V.’s lab was supported by MICIU PID2020-114630GB-I00 and ERC-AdG-LS2-670146I and the Generalitat de Catalunya through the CERCA programme. M.A.N. and J.V. also acknowledge financial support from the Spanish State Research Agency, through the ‘Severo Ochoa Programme’ for Centres of Excellence in R&D, Grants CEX2021-001165-S and CEX2020-001049-S, respectively. A.G.-I. was holder of a FPU predoctoral contract from the Spanish Ministry of Education, Culture and Sports.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia

  • López-Oreja, Irene
  • Gohr, André
  • Playa-Albinyana, Heribert
  • Giró, Ariadna
  • Arenas, Fabián
  • Higashi, Morihiro
  • Tripathi, Rupal
  • López-Guerra, Mónica
  • Irimia Martínez, Manuel
  • Aymerich, Marta
  • Valcárcel, J. (Juan)
  • Bonnal, Sophie
  • Colomer Pujol, Dolors
Splicing factor 3B subunit 1 (SF3B1) is involved in pre-mRNA branch site recognition and is the target of antitumor-splicing inhibitors. Mutations in SF3B1 are observed in 15% of patients with chronic lymphocytic leukemia (CLL) and are associated with poor prognosis, but their pathogenic mechanisms remain poorly understood. Using deep RNA-sequencing data from 298 CLL tumor samples and isogenic SF3B1 WT and K700E-mutated CLL cell lines, we characterize targets and pre-mRNA sequence features associated with the selection of cryptic 3' splice sites upon SF3B1 mutation, including an event in the MAP3K7 gene relevant for activation of NF-κB signaling. Using the H3B-8800 splicing modulator, we show, for the first time in CLL, cytotoxic effects in vitro in primary CLL samples and in SF3B1-mutated isogenic CLL cell lines, accompanied by major splicing changes and delayed leukemic infiltration in a CLL xenotransplant mouse model. H3B-8800 displayed preferential lethality towards SF3B1-mutated cells and synergism with the BCL2 inhibitor venetoclax, supporting the potential use of SF3B1 inhibitors as a novel therapeutic strategy in CLL., The work of the authors is supported by the Spanish Ministry of Science and Innovation through the Plan Estatal de Investigación Científica y Técnica y de Innovación (RTI2018-094584-B-I00; PID2021-123165OB-I00; BFU-2017-89308-P, PID2020-114630GB-I00) and was cofounded by the European Regional Development Fund (ERDF), European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program ERC-AdG-LS2-670146 l, CERCA program from Generalitat de Catalunya, Centre of Excellence Severo Ochoa Award (CEX2020-001049) to the Centre for Genomic Regulation of the Barcelona Institute of Science and Technology, Centro de Investigación Biomédica en Cáncer (CIBERONC) (CB16/12/334), Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya (2017 SGR 1009; 2021 SGR-1294) and Asociación Española Contra el Cancer (AECC) (PRYGN223298VALC). We thank Elias Campo for sharing transcriptomics data from ICGC consortium and for reviewing the manuscript. We thank Suzanne Mays, Estefania Mancini, Malgorzata Rogalska, and Ferran Nadeu for their help and all the laboratory members from Juan Valcarcel’s group.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

  • Baeza Centurión, Pablo, 1989-
  • Miñana Gómez, Belén
  • Faure, Andre J.
  • Thompson, Mike
  • Bonnal, Sophie
  • Quarantani, Gioia
  • Clarke, Joseph
  • Lehner, Ben, 1978-
  • Valcárcel, J. (Juan)
While altered pre-mRNA splicing is a frequent mechanism by which genetic variants cause disease, the regulatory architecture of human exons remains poorly understood. Antisense oligonucleotides (AONs) that target pre-mRNA splicing have been approved as therapeutics for various pathologies including patient-customised treatments for rare diseases, but AON discovery is currently slow and expensive, limiting the wider adoption of the approach. Here we show that deep indel mutagenesis (DIM) -which can be made experimentally at very low cost - provides an efficient strategy to chart the regulatory landscape of human exons and rapidly identify candidate splicing-modulating oligonucleotides. DIM reveals autonomous effects of insertions, while systematic deletion scans delineate the checkerboard architecture of sequential enhancers and silencers in a model alternative exon. The results also suggest a mechanism for repression of transmembrane domain-encoding exons and for the generation of microexons. Leveraging deep learning tools, we provide a resource, DANGO, that predicts the splicing regulatory landscape of all human exons and can help to identify effective splicing-modulating antisense oligonucleotides., This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreements 670146 and 883742) and from the European Union's Horizon Europe under the grant agreement No 101071936. We also acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. We received funding from the Spanish State Research Agency (PID2020-114630GB-I00/AEI/10.13039/501100011033), LCF/PR/HR21/52410004, EMBL Partnership, the Bettencourt Schueller Foundation, the AXA Research Fund, and Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322). GQ was supported by PRE2022-102744, financed by MCIN/AEI/10.13039/501100011033 and FSE + . J.C. is funded by the BBSRC DTP (Bio-technology and Biological Sciences Research Council, Biosciences Doctoral Training Programme, Cambridge, UK. The Genotype-Tissue Expression (GTEx) data used for the analyses described in this manu-script were obtained from the GTEx Portal on May 8, 2018 and dbGaP accession number phs000424.v7.p2 on May 8, 2018. The GTEx Project was supported by the Common Fund of the Office of the Director of the NIH and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intron detention tightly regulates the stemness/differentiation switch in the adult neurogenic niche

  • González-Iglesias, Ainara
  • Arcas, Aída
  • Domingo-Muelas, Ana
  • Mancini, Estefanía
  • Galcerán, Joan
  • Valcárcel, Juan
  • Fariñas, Isabel
  • Nieto, M. Ángela
The adult mammalian brain retains some capacity to replenish neurons and glia, holding promise for brain regeneration. Thus, understanding the mechanisms controlling adult neural stem cell (NSC) differentiation is crucial. Paradoxically, adult NSCs in the subependymal zone transcribe genes associated with both multipotency maintenance and neural differentiation, but the mechanism that prevents conflicts in fate decisions due to these opposing transcriptional programmes is unknown. Here we describe intron detention as such control mechanism. In NSCs, while multiple mRNAs from stemness genes are spliced and exported to the cytoplasm, transcripts from differentiation genes remain unspliced and detained in the nucleus, and the opposite is true under neural differentiation conditions. We also show that m6A methylation is the mechanism that releases intron detention and triggers nuclear export, enabling rapid and synchronized responses. m6A RNA methylation operates as an on/off switch for transcripts with antagonistic functions, tightly controlling the timing of NSCs commitment to differentiation., This work was supported by grants to M.A.N. from the Spanish Ministry of Science and Innovation (MCI PID2021-125682NB-I00), Instituto de Salud Carlos III (CIBERER/19/3.1), and Generalitat Valenciana (GVA) (ISIC 2012/010 plus Prometeo Programme 2017/150 and 2021/045). Work in I.F.’s lab was supported by MICIU grants PID2020-117937GB-I00, RED2018- 102723-T, CB06/05/0086 (CIBERNED), and RD16/0011/0017 (RETIC Tercel) plus Prometeo 2017/030. Work in J.V.’s lab was supported by MICIU PID2020-114630GB-I00 and ERC-AdG-LS2-670146I and the Generalitat de Catalunya through the CERCA programme. M.A.N. and J.V. also acknowledge financial support from the Spanish State Research Agency, through the ‘Severo Ochoa Programme’ for Centres of Excellence in R&D, Grants CEX2021-001165-S and CEX2020-001049-S, respectively. A.G.-I. was holder of a FPU predoctoral contract from the Spanish Ministry of Education, Culture and Sports., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001165-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2020-001049-S)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia

  • López-Oreja, Irene
  • Gohr, André
  • Playa-Albinyana, Heribert
  • Giró, Ariadna
  • Arenas, Fabián
  • Higashi, Morihiro
  • Tripathi, Rupal
  • López-Guerra, Mónica
  • Irimia Martínez, Manuel
  • Aymerich, Marta
  • Valcárcel, J. (Juan)
  • Bonnal, Sophie
  • Colomer Pujol, Dolors
Splicing factor 3B subunit 1 (SF3B1) is involved in pre-mRNA branch site recognition and is the target of antitumor-splicing inhibitors. Mutations in SF3B1 are observed in 15% of patients with chronic lymphocytic leukemia (CLL) and are associated with poor prognosis, but their pathogenic mechanisms remain poorly understood. Using deep RNA-sequencing data from 298 CLL tumor samples and isogenic SF3B1 WT and K700E-mutated CLL cell lines, we characterize targets and pre-mRNA sequence features associated with the selection of cryptic 3' splice sites upon SF3B1 mutation, including an event in the MAP3K7 gene relevant for activation of NF-κB signaling. Using the H3B-8800 splicing modulator, we show, for the first time in CLL, cytotoxic effects in vitro in primary CLL samples and in SF3B1-mutated isogenic CLL cell lines, accompanied by major splicing changes and delayed leukemic infiltration in a CLL xenotransplant mouse model. H3B-8800 displayed preferential lethality towards SF3B1-mutated cells and synergism with the BCL2 inhibitor venetoclax, supporting the potential use of SF3B1 inhibitors as a novel therapeutic strategy in CLL., The work of the authors is supported by the Spanish Ministry of Science and Innovation through the Plan Estatal de Investigación Científica y Técnica y de Innovación (RTI2018-094584-B-I00; PID2021-123165OB-I00; BFU-2017-89308-P, PID2020-114630GB-I00) and was cofounded by the European Regional Development Fund (ERDF), European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program ERC-AdG-LS2-670146 l, CERCA program from Generalitat de Catalunya, Centre of Excellence Severo Ochoa Award (CEX2020-001049) to the Centre for Genomic Regulation of the Barcelona Institute of Science and Technology, Centro de Investigación Biomédica en Cáncer (CIBERONC) (CB16/12/334), Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya (2017 SGR 1009; 2021 SGR-1294) and Asociación Española Contra el Cancer (AECC) (PRYGN223298VALC). We thank Elias Campo for sharing transcriptomics data from ICGC consortium and for reviewing the manuscript. We thank Suzanne Mays, Estefania Mancini, Malgorzata Rogalska, and Ferran Nadeu for their help and all the laboratory members from Juan Valcarcel’s group.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

  • Baeza Centurión, Pablo, 1989-
  • Miñana Gómez, Belén
  • Faure, Andre J.
  • Thompson, Mike
  • Bonnal, Sophie
  • Quarantani, Gioia
  • Clarke, Joseph
  • Lehner, Ben, 1978-
  • Valcárcel, J. (Juan)
While altered pre-mRNA splicing is a frequent mechanism by which genetic variants cause disease, the regulatory architecture of human exons remains poorly understood. Antisense oligonucleotides (AONs) that target pre-mRNA splicing have been approved as therapeutics for various pathologies including patient-customised treatments for rare diseases, but AON discovery is currently slow and expensive, limiting the wider adoption of the approach. Here we show that deep indel mutagenesis (DIM) -which can be made experimentally at very low cost - provides an efficient strategy to chart the regulatory landscape of human exons and rapidly identify candidate splicing-modulating oligonucleotides. DIM reveals autonomous effects of insertions, while systematic deletion scans delineate the checkerboard architecture of sequential enhancers and silencers in a model alternative exon. The results also suggest a mechanism for repression of transmembrane domain-encoding exons and for the generation of microexons. Leveraging deep learning tools, we provide a resource, DANGO, that predicts the splicing regulatory landscape of all human exons and can help to identify effective splicing-modulating antisense oligonucleotides., This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreements 670146 and 883742) and from the European Union's Horizon Europe under the grant agreement No 101071936. We also acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. We received funding from the Spanish State Research Agency (PID2020-114630GB-I00/AEI/10.13039/501100011033), LCF/PR/HR21/52410004, EMBL Partnership, the Bettencourt Schueller Foundation, the AXA Research Fund, and Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322). GQ was supported by PRE2022-102744, financed by MCIN/AEI/10.13039/501100011033 and FSE + . J.C. is funded by the BBSRC DTP (Bio-technology and Biological Sciences Research Council, Biosciences Doctoral Training Programme, Cambridge, UK. The Genotype-Tissue Expression (GTEx) data used for the analyses described in this manu-script were obtained from the GTEx Portal on May 8, 2018 and dbGaP accession number phs000424.v7.p2 on May 8, 2018. The GTEx Project was supported by the Common Fund of the Office of the Director of the NIH and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Intron detention tightly regulates the stemness/differentiation switch in the adult neurogenic niche

  • González Iglesias, Ainara
  • Arcas Mantas, Aida
  • Domingo Muelas, Ana
  • Mancini, Estefanía
  • Galcerán, Joan
  • Valcárcel, J. (Juan)
  • Fariñas, Isabel
  • Nieto, M. Ángela
The adult mammalian brain retains some capacity to replenish neurons and glia, holding promise for brain regeneration. Thus, understanding the mechanisms controlling adult neural stem cell (NSC) differentiation is crucial. Paradoxically, adult NSCs in the subependymal zone transcribe genes associated with both multipotency maintenance and neural differentiation, but the mechanism that prevents conflicts in fate decisions due to these opposing transcriptional programmes is unknown. Here we describe intron detention as such control mechanism. In NSCs, while multiple mRNAs from stemness genes are spliced and exported to the cytoplasm, transcripts from differentiation genes remain unspliced and detained in the nucleus, and the opposite is true under neural differentiation conditions. We also show that m6A methylation is the mechanism that releases intron detention and triggers nuclear export, enabling rapid and synchronized responses. m6A RNA methylation operates as an on/off switch for transcripts with antagonistic functions, tightly controlling the timing of NSCs commitment to differentiation., This work was supported by grants to M.A.N. from the Spanish Ministry of Science and Innovation (MCI PID2021-125682NB-I00), Instituto de Salud Carlos III (CIBERER/19/3.1), and Generalitat Valenciana (GVA) (ISIC 2012/010 plus Prometeo Programme 2017/150 and 2021/045). Work in I.F.’s lab was supported by MICIU grants PID2020-117937GB-I00, RED2018- 102723-T, CB06/05/0086 (CIBERNED), and RD16/0011/0017 (RETIC Tercel) plus Prometeo 2017/030. Work in J.V.’s lab was supported by MICIU PID2020-114630GB-I00 and ERC-AdG-LS2-670146I and the Generalitat de Catalunya through the CERCA programme. M.A.N. and J.V. also acknowledge financial support from the Spanish State Research Agency, through the ‘Severo Ochoa Programme’ for Centres of Excellence in R&D, Grants CEX2021-001165-S and CEX2020-001049-S, respectively. A.G.-I. was holder of a FPU predoctoral contract from the Spanish Ministry of Education, Culture and Sports.